Investing Ideas
/
Hong Kong Healthcare High Insider Buying

Hong Kong Healthcare High Insider Buying

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

11 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
3390 Tycoon Group Holdings	HK$3.40	-2.9%	-26.4%	HK$2.7b	n/a	PE11.8x	n/a	0%
1526 New Rici Healthcare Holdings	HK$1.23	3.4%	5.1%	HK$2.0b	n/a	PE5.7x	n/a	7.0%
2407 Gaush Meditech	HK$9.73	-2.7%	-74.3%	HK$1.4b	n/a	PE14.9x	n/a	10.8%
9686 Xikang Cloud Hospital Holdings	HK$1.19	12.3%	-13.1%	HK$1.0b	n/a	PS1.9x	n/a	n/a
3689 Guangdong Kanghua Healthcare Group	HK$1.80	0%	-8.2%	HK$601.9m	n/a	PE11.1x	n/a	0%
2189 Kato (Hong Kong) Holdings	HK$0.50	4.2%	-3.8%	HK$500.0m	n/a	PE7.2x	n/a	0%
1120 Arts Optical International Holdings	HK$0.94	0%	9.3%	HK$363.1m	n/a	PE11.3x	n/a	5.3%
722 UMP Healthcare Holdings	HK$0.41	-1.2%	-31.4%	HK$323.8m	n/a	PE8x	n/a	8.1%
2216 Broncus Holding	HK$0.60	1.7%	-24.1%	HK$316.3m	HK$1.07	PS4.7x	S25.6%	n/a
1110 Kingworld Medicines Group	HK$0.45	-1.1%	-28.6%	HK$266.9m	n/a	PE8.1x	n/a	7.2%
1134 Kelfred Holdings	HK$0.25	-0.8%	-44.9%	HK$124.0m	n/a	PS0.3x	n/a	0%

Page 1 of 1